Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)

Clinical trial NCT06683092 · RECRUITING

Trial details

NCT number: NCT06683092
Sponsor: Boston Children's Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Cystic Fibrosis

Start date: 2025-05-01
Primary completion: 2028-03-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.